Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01602744
Other study ID # 0036-12 WOMC
Secondary ID
Status Completed
Phase N/A
First received May 1, 2012
Last updated March 23, 2014
Start date April 2012
Est. completion date September 2013

Study information

Verified date March 2014
Source Wolfson Medical Center
Contact n/a
Is FDA regulated No
Health authority Israel: Ethics Commission
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine if the use of STOPP/START criteria (STOPP-screening tool of older persons potentially inappropriate prescriptions START-screening tool to alert doctors to right treatment)for medication intervention in elderly population living in a geriatric hospital will lower the number of falls,hospitalization,will improve functioning, quality of life and reduce financial costs.


Description:

Inappropriate prescribing is common in older people and is associated with adverse drug effects,hospitalization and falls. In this trial we want to check the efficacy of the screening tools STOPP/START which were developed and validated in order to reduce inappropriate prescribing. STOPP comprises of 65 indicators of drug-drug, drug-disease interactions and therapeutic duplication. START incorporates 22 evidence based indicators of common prescribing omissions. We will conduct a randomized controlled trial to test the hypothesis that screening the medications of older patients living permanently in a geriatric hospital will improve their quality of life. The compliance of the doctor working in the geriatric hospital to the recommendations of the screening tools will also be checked.


Recruitment information / eligibility

Status Completed
Enrollment 382
Est. completion date September 2013
Est. primary completion date September 2013
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 65 Years and older
Eligibility Inclusion Criteria:

- age over 65

- live in the geriatric hospital "Givaat Hashlosha" permanently.

Exclusion Criteria:

- people with a terminal illness that will not live more than a year.

- people who enter the geriatric hospital for a short while (are not permanent).

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Screening


Related Conditions & MeSH terms


Intervention

Other:
STOPP/START screening tools for medication intervention
In the intervention arm the investigator will use the screening tools STOPP/START to screen the medications.

Locations

Country Name City State
Israel Givaat Hashlosha Geriatric Hospital Petach Tikva

Sponsors (1)

Lead Sponsor Collaborator
Wolfson Medical Center

Country where clinical trial is conducted

Israel, 

Outcome

Type Measure Description Time frame Safety issue
Primary Quality of Life- Mental Component Summaty (MCS) Quality of life will be measured by MOS SF-12 Health Survey questionnare. Results are expressed in terms of two meta scores: The Physical Component Summary(PCS) and the Mental Component Summary (MCS). The PCS and MCS scores have a range of 0 to 100, thus scores greater than 50 represent a better than average health status. Outcome measures were assessed at the end of the 12 month follow up No
Primary SF-12 Health Survey questionnaire-the Physical Component Summary (PCS) Quality of life was assessed by the SF-12 Health Survey questionnare. Results are expressed in terms of two meta scores:the Physical Component Summary (PCS) AND Mental Component Summary (MCS). The PCS and MCS scores have a range of 0 to 100, thus scores greater than 50 represent a better than average health status. Outcome measures were assessed at the end of the 12 month follow up No
Primary Falls Average number of falls per year. At the end of the 12 month follow up Yes
Primary Hospitalizations The average number of hospitalizations per year. Outcome measures were assessed at the end of the 12 month follow up Yes
Primary Functional Independence Measure (FIM) Functioning was assessed by the FIM score. The FIM rates 18 activities of daily living on a 7 point scale ranging from fully dependent (=1) to independent (=7). A maximum score of 126 indicates functional independence and the lowest score of 18 indicates functional dependence. Outcome measures were assessed at the end of the 12 month follow up No
Secondary Pharmacoeconomics Analysis-Costs of Medication The costs on medications in the geriatric hospital before and after intervention e.g. pharmaeconomic analysis of the intervention. Costs of medications were calculated in New Israeli shekels per month and taken from the Ministry of Health's medication price list. Outcome measures were assessed at the end of the 12 month follow up No